During the past decade, Orthopädische Klinik Markgröningen gGmbH conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orthopädische Klinik Markgröningen gGmbH" #1 collaborator was "Aesculap AG" with 1 trials as a collaborator and "Winicker Norimed GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Orthopädische Klinik Markgröningen gGmbH" are "Aseptic Loosening of Prosthetic Joint" (1 trials), "Cartilage Disease" (1 trials) and "Infection of Total Knee Joint Prosthesis" (1 trials). Many other conditions were trialed in "Orthopädische Klinik Markgröningen gGmbH" in a lesser frequency.

Most popular intervention types in "Orthopädische Klinik Markgröningen gGmbH" are "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aquamantys System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orthopädische Klinik Markgröningen gGmbH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Orthopädische Klinik Markgröningen gGmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Orthopädische Klinik Markgröningen gGmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orthopädische Klinik Markgröningen gGmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".